Trending Now

Nivesh.live

Invest Wisely, Grow Steadily

Menu
Search
Headline
10 reasons why gold is a good buy in 2025 – CNBC TV18
10 reasons why gold is a good buy in 2025 – CNBC TV18
Tata Motors shares up 5% but tariff troubles continue to linger – CNBC TV18
Tata Motors shares up 5% but tariff troubles continue to linger – CNBC TV18
Muthoot Finance shares fall over 8% in reaction to draft RBI norms, Kotak downgrade – CNBC TV18
Muthoot Finance shares fall over 8% in reaction to draft RBI norms, Kotak downgrade – CNBC TV18
National Pet Day 2025: A look at pet insurance coverage in India and what’s included – CNBC TV18
National Pet Day 2025: A look at pet insurance coverage in India and what’s included – CNBC TV18
Bharti Hexacom shares in focus after deal to sell 3,400 towers to Indus Towers halted – CNBC TV18
Bharti Hexacom shares in focus after deal to sell 3,400 towers to Indus Towers halted – CNBC TV18
Samvardhana Motherson aims for €50 million in cost savings with latest measures – CNBC TV18
Samvardhana Motherson aims for €50 million in cost savings with latest measures – CNBC TV18
Asian shares sink, with Japan’s Nikkei down 5.6% as China-US trade war escalates – CNBC TV18
Asian shares sink, with Japan’s Nikkei down 5.6% as China-US trade war escalates – CNBC TV18
GIFT Nifty surges nearly 500 points indicating a potential gap-up despite US sell-off – CNBC TV18
GIFT Nifty surges nearly 500 points indicating a potential gap-up despite US sell-off – CNBC TV18
Sensex Today | Stock Market LIVE Updates: Sensex, Nifty 50 likely to make a gap down start on Wednesday
Sensex Today | Stock Market LIVE Updates: Sensex, Nifty 50 likely to make a gap down start on Wednesday

Tag: Glenmark Pharmaceuticals share price

Markets
Sarvesh Gautam

Glenmark Pharma stages smart recovery in Q3 with ₹348-crore net profit on higher revenues – CNBC TV18

[ad_1] Glenmark Pharmaceuticals Ltd on Friday (February 14) reported a net profit of ₹347.9 crore for Q3FY25, recovering from a net loss of ₹351.3 crore. Company Value Change %Change Revenue from operations surged 35.1% to ₹3,387.6 crore against ₹2,506.7 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA zoomed to […]

Markets
Sarvesh Gautam

Glenmark Pharmaceuticals gets ₹121.25 crore GST demand, plans to appeal – CNBC TV18

[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Friday (February 7) said it has received an order from the Joint Commissioner of Central Goods and Services Tax and Central Excise (CGST & CX) Palghar, Maharashtra, seeking ₹121.25 crore in tax, interest, and penalties from 2017-18 to 2021-22. Company Value Change %Change The order includes a demand […]

Markets
Sarvesh Gautam

Glenmark Pharma share price: Ashish Dhawan portfolio stock surges 9% as USFDA clears Aurangabad unit – CNBC TV18

[ad_1] Shares of Glenmark Pharmaceuticals Ltd. surged by as much as 9% during Monday’s trading session. The sharp uptick in the stock price was seen after the US Food and Drug Administration (FDA) issued a Form 483 with zero observations for the company’s manufacturing facility in Chhatrapati Sambhaji Nagar (Aurangabad). The US FDA conducted […]

Markets
Sarvesh Gautam

Glenmark Pharma Aurangabad unit clears FDA test – CNBC TV18

[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Friday (September 20) said its formulation manufacturing facility in Chhatrapati Sambhaji Nagar (Aurangabad), has successfully completed a routine inspection by the US Food and Drug Administration (FDA). “This is to inform you that the U.S. FDA has issued Form 483 with zero observations after an inspection at the […]

Back To Top
Translate »